The global immunohistochemistry (IHC) market is expected to grow from USD 3.5 billion in 2024 to USD 7.4 billion by 2034, reflecting a CAGR of 7.8% over the forecast period.
Request a Sample Copy of This Report Now: https://www.futuremarketinsights.com/report-sample#5245502d47422d3134383038
Key Market Drivers & Trends:
Advancements in Multiplexing Techniques:
IHC now enables the simultaneous detection of multiple biomarkers, improving diagnostic precision.
Integration of AI & Digital Pathology:
Artificial intelligence and automated image analysis are enhancing workflow efficiency and diagnostic accuracy in IHC applications.
Growth in Companion Diagnostics & Immunotherapy:
The rise of personalized medicine has driven the use of IHC in oncology trials, particularly for companion diagnostic assays in immunotherapy.
Focus on Quality Control & Standardization:
Efforts to improve reproducibility and standardization are making IHC assays more reliable and consistent for both clinical and research applications.
Expanding Applications Beyond Oncology:
While widely used in cancer diagnostics, IHC is also gaining traction in immunology, neuroscience, and infectious disease research.
Future Outlook: A Growing Market with Expanding Applications
The increasing role of precision medicine, AI-driven pathology, and biomarker discovery will drive further expansion in the IHC market, making it a key area of innovation in diagnostics and drug development.
Key Market Trends and Highlights
- Advancements in Multiplexing Techniques:
- The development of multiplexing techniques allows for the simultaneous detection of multiple biomarkers, enhancing diagnostic capabilities and providing deeper insights into disease pathology.
- Integration of Artificial Intelligence:
- The combination of artificial intelligence (AI) and digital pathology is improving workflow efficiency and diagnostic accuracy in immunohistochemistry, enabling more precise analysis of tissue samples.
- Rise of Companion Diagnostics:
- Companion diagnostic assays are driving the development of immunohistochemistry-based immunotherapy trials, particularly in oncology, where identifying specific biomarkers is crucial for effective treatment planning.
- Focus on Quality Control and Standardization:
- As the importance of quality control and standardization increases, immunohistochemistry assays are becoming more reliable and repeatable, which is essential for clinical applications.
- Expanding Applications Beyond Oncology:
- Immunohistochemistry’s therapeutic significance extends beyond oncology to fields such as immunology, neuroscience, and infectious diseases, broadening its market potential.
Key Companies Profiled
Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Merck KGaA; Danaher Corporation; Perkinelmer Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; Bio SB; Agilent Technologies Inc.; Abcam plc.
Immunohistochemistry (IHC) – Key Segments
By Product:
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining System
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Reagents
- Histological stains
- Blocking Sera & Reagents
- Chromogenic Substrates
- Fixation Reagents
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Other Reagents
- Kits
By Application:
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Research
By End User:
- Hospitals & Diagnostic Laboratories
- Research Institutes
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
